Yantai Dongcheng Biochemicals (002675.SZ): Jiangxi Yichun Nuclear Medicine Production Center Commences Operations

Stock Track07-15

Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. ("Jiangxi Andike") has received the Drug GMP Compliance Inspection Results Notification from the Jiangxi Provincial Medical Products Administration. This certification enables the newly established nuclear medicine production facility in Yichun, Jiangxi Province to begin commercial operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107591808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-15 18:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107591808","market":"sg","top_or_hot":-1,"title":"Yantai Dongcheng Biochemicals (002675.SZ): Jiangxi Yichun Nuclear Medicine Production Center Commences Operations","media":"Stock Track","content":"<p>Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. (\"Jiangxi Andike\") has received the Drug GMP Compliance Inspection Results Notification from the Jiangxi Provincial Medical Products Administration. This certification enables the newly established nuclear medicine production facility in Yichun, Jiangxi Province to begin commercial operations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yantai Dongcheng Biochemicals (002675.SZ): Jiangxi Yichun Nuclear Medicine Production Center Commences Operations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYantai Dongcheng Biochemicals (002675.SZ): Jiangxi Yichun Nuclear Medicine Production Center Commences Operations\n</h2>\n\n<h4 class=\"meta\">\n\n2025-07-15 18:12 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. (\"Jiangxi Andike\") has received the Drug GMP Compliance ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002675","symbol_name":"东诚药业","start_time":0,"source_url":"","article_id":"1107591808","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107591808","pubTimestamp":1752574330,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":null,"summary":"Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. (\"Jiangxi Andike\") has received the Drug GMP Compliance...","collect":0,"end_time":0,"defaultTopTitle":"laohu8.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"002675":"东诚药业","BK0239":"医药制造"},"translate_title":"烟台东城生化（002675.SZ）：江西宜春核药生产中心投产","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002675":1},"content_text":"Yantai Dongcheng Biochemicals Co., Ltd. (002675.SZ) announced that its wholly-owned subsidiary Jiangxi Andike Pharmaceutical Co., Ltd. (\"Jiangxi Andike\") has received the Drug GMP Compliance Inspection Results Notification from the Jiangxi Provincial Medical Products Administration. This certification enables the newly established nuclear medicine production facility in Yichun, Jiangxi Province to begin commercial operations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107591808","isCrawlerRequest":true}